Glytrix - AngelList

Product

Glytrix is an early stage biotech company that is developing a novel platform technology for tissue healing and regeneration. We are leading this development with Pellagen, a locally delivered drug in late stage preclinical development for promoting healthy scar-free healing in the skin.

Founders

You may be banned if you request references from people you don't know well. References will be required to write a comment. You cannot request references from investors.

Name

Email for confirmation

Mini-resume (160 characters max)
Always Show

Describe this person's previous achievements to a potential investor

Cancel
Eric Morrel

VP Clinical Research and Co-Founder at LipimetiX
Phil Friden

Vice President R&D and Co-Founder at LipimetiX, LLC
Kate Stuart

Co-founded Glytrix and has >11yrs experience in biomaterials and collagen expertise and inventor on 3 patent applications with Glytrix.
Dennis Goldberg

Has >20 yrs experience in pharma/biotech industry. Founded and led as CEO several companies including Talaria Therapeutics, acquired by Esperion in <2 yrs.
Alyssa Panitch

Associate Head of Biomedical Engineering at Purdue with numerous publications/patents in biomimetic materials, and founded 3 companies.
John Paderi

Co-founded Glytrix following PhD work to develop platform technology that promotes scar-free tissue healing. Inventor on 5 patent applications from Purdue.

Incubator

Incubated by

Cancel